# Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients

> **NCT00620438** · PHASE4 · UNKNOWN · sponsor: **Makerere University** · enrollment: 90 (estimated)

## Conditions studied

- HIV Infections
- Tuberculosis

## Interventions

- **DRUG:** Lumefantrine-artemether and nevirapine
- **DRUG:** lumefantrine-artemether and efavirenz
- **DRUG:** Lumefantrine-artemether and rifampicin

## Key facts

- **NCT ID:** NCT00620438
- **Lead sponsor:** Makerere University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-02
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2010-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00620438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00620438, "Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00620438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*